BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17608466)

  • 21. Hamycin inhibits IL-8-induced biologic response by modulating its receptor in human polymorphonuclear neutrophils.
    Manna SK; Samanta S; Samanta AK
    J Immunol; 1997 Nov; 159(10):5042-52. PubMed ID: 9366432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of neutrophil apoptosis in plasma of patients after orthognathic surgery.
    Suzuki R; Iwase M; Miyaoka K; Kondo G; Watanabe H; Ohashi M; Nagumo M
    J Surg Res; 2006 Jan; 130(1):110-8. PubMed ID: 16289597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration.
    White JR; Lee JM; Young PR; Hertzberg RP; Jurewicz AJ; Chaikin MA; Widdowson K; Foley JJ; Martin LD; Griswold DE; Sarau HM
    J Biol Chem; 1998 Apr; 273(17):10095-8. PubMed ID: 9553055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationships of pyrazolodiazepine derivatives as human P2X7 receptor antagonists.
    Lee JY; Yu J; Cho WJ; Ko H; Kim YC
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6053-8. PubMed ID: 19800793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant.
    Eckert RE; Jones SL
    J Leukoc Biol; 2007 Nov; 82(5):1311-21. PubMed ID: 17684042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists.
    Biju P; Taveras A; Yu Y; Zheng J; Chao J; Rindgen D; Jakway J; Hipkin RW; Fossetta J; Fan X; Fine J; Qiu H; Merritt JR; Baldwin JJ
    Bioorg Med Chem Lett; 2008 Jan; 18(1):228-31. PubMed ID: 18006311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists.
    Chao J; Taveras AG; Chao J; Aki C; Dwyer M; Yu Y; Purakkattle B; Rindgen D; Jakway J; Hipkin W; Fosetta J; Fan X; Lundell D; Fine J; Minnicozzi M; Phillips J; Merritt JR
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3778-83. PubMed ID: 17459706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of an activation factor released from human neutrophils after stimulation by triclinic monosodium urate crystals.
    Desaulniers P; Marois S; Paré G; Popa-Nita O; Gilbert C; Naccache PH
    J Rheumatol; 2006 May; 33(5):928-38. PubMed ID: 16652423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of immunosuppressive regimens on neutrophil chemotaxis.
    Di Stefano R; Scavuzzo M; Pietrabissa A; Donati D; Carmellini M; Rizzo G; Rindi P; Mosca F
    Transplant Proc; 1994 Oct; 26(5):2861-2. PubMed ID: 7940901
    [No Abstract]   [Full Text] [Related]  

  • 30. Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats.
    Auten RL; Richardson RM; White JR; Mason SN; Vozzelli MA; Whorton MH
    J Pharmacol Exp Ther; 2001 Oct; 299(1):90-5. PubMed ID: 11561067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III.
    Dunzendorfer S; Kaneider N; Rabensteiner A; Meierhofer C; Reinisch C; Römisch J; Wiedermann CJ
    Blood; 2001 Feb; 97(4):1079-85. PubMed ID: 11159540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: synthesis, nitric oxide release studies and anti-inflammatory activities.
    Abdellatif KR; Chowdhury MA; Dong Y; Knaus EE
    Bioorg Med Chem; 2008 Jul; 16(13):6528-34. PubMed ID: 18513975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 8 and cell migration to inflammatory sites: the regulation of focal adhesion kinase under conditions of migratory desensitization.
    Cohen-Hillel E; Yron I; Meshel T; Ben-Baruch A
    Isr Med Assoc J; 2007 Aug; 9(8):579-83. PubMed ID: 17877062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of jarastatin, a novel snake venom disintegrin, on neutrophil migration and actin cytoskeleton dynamics.
    Coelho AL; de Freitas MS; Oliveira-Carvalho AL; Moura-Neto V; Zingali RB; Barja-Fidalgo C
    Exp Cell Res; 1999 Sep; 251(2):379-87. PubMed ID: 10471323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors.
    Romeo G; Salerno L; Milla P; Siracusa M; Cattel L; Russo F
    Pharmazie; 1999 Jan; 54(1):19-23. PubMed ID: 9987793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of N-4,6-pyrimidine-N-alkyl-N'-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase.
    Maier JA; Brugel TA; Sabat M; Golebiowski A; Laufersweiler MJ; VanRens JC; Hopkins CR; De B; Hsieh LC; Brown KK; Easwaran V; Janusz MJ
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3646-50. PubMed ID: 16682201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and antiinflammatory activity of novel phthalimide derivatives, structurally related to thalidomide.
    Machado AL; Lima LM; Araújo JX; Fraga CA; Koatz VL; Barreiro EJ
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1169-72. PubMed ID: 15686935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of some hydroxypyrazole derivatives as anti-inflammatory-antimicrobial agents.
    Bekhit AA; Abdel-Rahman HM; Guemei AA
    Arch Pharm (Weinheim); 2006 Feb; 339(2):81-7. PubMed ID: 16470641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities.
    Bruno O; Ranise A; Bondavalli F; Schenone P; D'Amico M; Filippelli A; Filippelli W; Rossi F
    Farmaco; 1993 Jul; 48(7):949-66. PubMed ID: 8397678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of a new interleukin-8 receptor in bovine species.
    Lahouassa H; Rainard P; Caraty A; Riollet C
    Mol Immunol; 2008 Feb; 45(4):1153-64. PubMed ID: 17727952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.